<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Contact Dermatitis From Topical Drug Products for Cutaneous Application: Human Safety Assessment; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Contact Dermatitis From Topical Drug Products for Cutaneous Application: Human Safety Assessment; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2020-03-09 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Contact Dermatitis From Topical Drug Products for Cutaneous Application: Human Safety Assessment." This draft guidance provides recommendations for the characterization, during product development, of local safety of topical drug products regarding the risk for contact dermatitis. These recommendations are specifically directed to development of topical new drug products int...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-04753</p>
    <p><strong>Publication Date:</strong> 2020-03-09</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/03/09/2020-04753/contact-dermatitis-from-topical-drug-products-for-cutaneous-application-human-safety-assessment">https://www.federalregister.gov/documents/2020/03/09/2020-04753/contact-dermatitis-from-topical-drug-products-for-cutaneous-application-human-safety-assessment</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-04753</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
